Matthew Hewitt

Stock Analyst at Craig-Hallum

(1.85)

# 3,140

Out of 5,174 analysts

4

Total ratings

50%

Success rate

5.54%

Average return

Main Sectors:

Top Industries:

Medical Devices Health Information Services Drug Manufacturers - Specialty & Generic

Stocks Rated by Matthew Hewitt

	Stock	Action	Price Target	Current	Upside	Ratings	Updated
	APYX Apyx Medical	Maintains: Buy	$5 → $6	$3.94	+52.28%	1	Mar 11, 2026
	CERT Certara	Initiates: Buy	$16	$6.25	+156.00%	1	Sep 29, 2025
	LFCR Lifecore Biomedical	Maintains: Buy	$8 → $10	$4.00	+150.00%	2	Nov 22, 2024

Apyx Medical

Mar 11, 2026

Maintains: Buy

Price Target: $5 → $6

Current: $3.94

Upside: +52.28%

Certara

Sep 29, 2025

Initiates: Buy

Price Target: $16

Current: $6.25

Upside: +156.00%

Lifecore Biomedical

Nov 22, 2024

Maintains: Buy

Price Target: $8 → $10

Current: $4.00

Upside: +150.00%